Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Comparison of dominant fund strategies for retirement, weighing SP 500 versus Total Market to guide your decision.
28,607 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
BigBear.AI released its latest quarterly results after the bell, showing a sharp balance-sheet improvement and a path...
As 2026 begins, homebuilders contend with thinner margins, stubborn demand, and growing war-risk headwinds, forcing l...
XRP exchange-traded funds booked their first monthly net outflow after a $1.2 billion rally, signaling a shift in inv...
A risk disclosure in SpaceX’s pre-IPO paperwork flags space-based warfare threats to Starlink. As investors watch an ...
Developers race to add native privacy to Ethereum as investors rotate into privacy-first assets. A 12-month deadline ...
A week of trouble tested Amazon's operations and investor nerves. This article breaks down two essential takeaways an...
Meta's AI forecast points to a near-term Bitcoin dip followed by a multi-week rally as ETF flows and policy catalysts...
The Department of Veterans Affairs rolled out changes to its home loan appraisal process, removing outdated rules and...
When a deal comes with no interior walkthrough, the smartest investors lean on data, systems, and creative financing....
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
Biotech stocks can swing wildly on quarterly results and guidance. This article unpacks why genedx stock plummeting t...